545 lines
166 KiB
Text
545 lines
166 KiB
Text
<!DOCTYPE html>
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" class="no-js no-jr">
|
|
<head>
|
|
<!-- For pinger, set start time and add meta elements. -->
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books">
|
|
<meta name="ncbi_pdid" content="book-part">
|
|
<meta name="ncbi_acc" content="NBK385288">
|
|
<meta name="ncbi_domain" content="gtrbook">
|
|
<meta name="ncbi_report" content="reader">
|
|
<meta name="ncbi_type" content="fulltext">
|
|
<meta name="ncbi_objectid" content="">
|
|
<meta name="ncbi_pcid" content="/NBK385288/?report=reader">
|
|
<meta name="ncbi_pagename" content="Aripiprazole Therapy and CYP2D6 Genotype - Medical Genetics Summaries - NCBI Bookshelf">
|
|
<meta name="ncbi_bookparttype" content="chapter">
|
|
<meta name="ncbi_app" content="bookshelf">
|
|
<!-- Logger end -->
|
|
|
|
<!--component id="Page" label="meta"/-->
|
|
<script type="text/javascript" src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.boots.min.js"> </script><title>Aripiprazole Therapy and CYP2D6 Genotype - Medical Genetics Summaries - NCBI Bookshelf</title>
|
|
<meta charset="utf-8">
|
|
<meta name="apple-mobile-web-app-capable" content="no">
|
|
<meta name="viewport" content="initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no">
|
|
<meta name="jr-col-layout" content="auto">
|
|
<meta name="jr-prev-unit" content="/books/n/gtrbook/amitriptyline/?report=reader">
|
|
<meta name="jr-next-unit" content="/books/n/gtrbook/atazanavir/?report=reader">
|
|
<meta name="bk-toc-url" content="/books/n/gtrbook/?report=toc">
|
|
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE">
|
|
<meta name="citation_inbook_title" content="Medical Genetics Summaries [Internet]">
|
|
<meta name="citation_title" content="Aripiprazole Therapy and CYP2D6 Genotype">
|
|
<meta name="citation_publisher" content="National Center for Biotechnology Information (US)">
|
|
<meta name="citation_date" content="2025/01/17">
|
|
<meta name="citation_author" content="Laura Dean">
|
|
<meta name="citation_author" content="Megan Kane">
|
|
<meta name="citation_pmid" content="28520375">
|
|
<meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK385288/">
|
|
<meta name="citation_keywords" content="Aripiprazole therapy">
|
|
<meta name="citation_keywords" content="aripiprazole response">
|
|
<meta name="citation_keywords" content="CYP2D6">
|
|
<meta name="citation_keywords" content="CYP2D6*1">
|
|
<meta name="citation_keywords" content="CYP2D6*2">
|
|
<meta name="citation_keywords" content="CYP2D6*3">
|
|
<meta name="citation_keywords" content="Abilify response">
|
|
<meta name="citation_keywords" content="Aristada response">
|
|
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/">
|
|
<meta name="DC.Title" content="Aripiprazole Therapy and CYP2D6 Genotype">
|
|
<meta name="DC.Type" content="Text">
|
|
<meta name="DC.Publisher" content="National Center for Biotechnology Information (US)">
|
|
<meta name="DC.Contributor" content="Laura Dean">
|
|
<meta name="DC.Contributor" content="Megan Kane">
|
|
<meta name="DC.Date" content="2025/01/17">
|
|
<meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK385288/">
|
|
<meta name="description" content="Aripiprazole (brand names Abilify or Aristada) is an atypical antipsychotic used to manage schizophrenia, bipolar disorder, major depressive disorder, irritability associated with autistic disorder, and in the treatment of Tourette syndrome. (1)">
|
|
<meta name="og:title" content="Aripiprazole Therapy and CYP2D6 Genotype">
|
|
<meta name="og:type" content="book">
|
|
<meta name="og:description" content="Aripiprazole (brand names Abilify or Aristada) is an atypical antipsychotic used to manage schizophrenia, bipolar disorder, major depressive disorder, irritability associated with autistic disorder, and in the treatment of Tourette syndrome. (1)">
|
|
<meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK385288/">
|
|
<meta name="og:site_name" content="NCBI Bookshelf">
|
|
<meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gtrbook-lrg.png">
|
|
<meta name="twitter:card" content="summary">
|
|
<meta name="twitter:site" content="@ncbibooks">
|
|
<meta name="bk-non-canon-loc" content="/books/n/gtrbook/aripiprazole/?report=reader">
|
|
<link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK385288/">
|
|
<link href="https://fonts.googleapis.com/css?family=Archivo+Narrow:400,700,400italic,700italic&subset=latin" rel="stylesheet" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/libs.min.css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/jr.min.css">
|
|
<meta name="format-detection" content="telephone=no">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css//books_print.min.css" type="text/css" media="print">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_reader.min.css" type="text/css">
|
|
<style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style>
|
|
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico">
|
|
<meta name="ncbi_phid" content="CE8EF32E7D5B9041000000000058004B.m_5">
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3849091.css"></head>
|
|
<body>
|
|
<!-- Book content! -->
|
|
|
|
|
|
<div id="jr" data-jr-path="/corehtml/pmc/jatsreader/ptpmc_3.22/"><div class="jr-unsupported"><table class="modal"><tr><td><span class="attn inline-block"></span><br />Your browser does not support the NLM PubReader view.<br />Go to <a href="/pmc/about/pr-browsers/">this page</a> to see a list of supported browsers<br />or return to the <br /><a href="/books/NBK385288/?report=classic">regular view</a>.</td></tr></table></div><div id="jr-ui" class="hidden"><nav id="jr-head"><div class="flexh tb"><div id="jr-tb1"><a id="jr-links-sw" class="hidden" title="Links"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" x="0px" y="0px" viewBox="0 0 70.6 85.3" style="enable-background:new 0 0 70.6 85.3;vertical-align:middle" xml:space="preserve" width="24" height="24">
|
|
<style type="text/css">.st0{fill:#939598;}</style>
|
|
<g>
|
|
<path class="st0" d="M36,0C12.8,2.2-22.4,14.6,19.6,32.5C40.7,41.4-30.6,14,35.9,9.8"></path>
|
|
<path class="st0" d="M34.5,85.3c23.2-2.2,58.4-14.6,16.4-32.5c-21.1-8.9,50.2,18.5-16.3,22.7"></path>
|
|
<path class="st0" d="M34.7,37.1c66.5-4.2-4.8-31.6,16.3-22.7c42.1,17.9,6.9,30.3-16.4,32.5h1.7c-66.2,4.4,4.8,31.6-16.3,22.7 c-42.1-17.9-6.9-30.3,16.4-32.5"></path>
|
|
</g>
|
|
</svg> Books</a></div><div class="jr-rhead f1 flexh"><div class="head"><a href="/books/n/gtrbook/amitriptyline/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="body"><div class="t">Aripiprazole Therapy and CYP2D6 Genotype</div><div class="j">Medical Genetics Summaries [Internet]</div></div><div class="tail"><a href="/books/n/gtrbook/atazanavir/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></div><div id="jr-tb2"><a id="jr-bkhelp-sw" class="btn wsprkl hidden" title="Help with NLM PubReader">?</a><a id="jr-help-sw" class="btn wsprkl hidden" title="Settings and typography in NLM PubReader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" preserveAspectRatio="none"><path d="M462,283.742v-55.485l-29.981-10.662c-11.431-4.065-20.628-12.794-25.274-24.001 c-0.002-0.004-0.004-0.009-0.006-0.013c-4.659-11.235-4.333-23.918,0.889-34.903l13.653-28.724l-39.234-39.234l-28.72,13.652 c-10.979,5.219-23.68,5.546-34.908,0.889c-0.005-0.002-0.01-0.003-0.014-0.005c-11.215-4.65-19.933-13.834-24-25.273L283.741,50 h-55.484l-10.662,29.981c-4.065,11.431-12.794,20.627-24.001,25.274c-0.005,0.002-0.009,0.004-0.014,0.005 c-11.235,4.66-23.919,4.333-34.905-0.889l-28.723-13.653l-39.234,39.234l13.653,28.721c5.219,10.979,5.545,23.681,0.889,34.91 c-0.002,0.004-0.004,0.009-0.006,0.013c-4.649,11.214-13.834,19.931-25.271,23.998L50,228.257v55.485l29.98,10.661 c11.431,4.065,20.627,12.794,25.274,24c0.002,0.005,0.003,0.01,0.005,0.014c4.66,11.236,4.334,23.921-0.888,34.906l-13.654,28.723 l39.234,39.234l28.721-13.652c10.979-5.219,23.681-5.546,34.909-0.889c0.005,0.002,0.01,0.004,0.014,0.006 c11.214,4.649,19.93,13.833,23.998,25.271L228.257,462h55.484l10.595-29.79c4.103-11.538,12.908-20.824,24.216-25.525 c0.005-0.002,0.009-0.004,0.014-0.006c11.127-4.628,23.694-4.311,34.578,0.863l28.902,13.738l39.234-39.234l-13.66-28.737 c-5.214-10.969-5.539-23.659-0.886-34.877c0.002-0.005,0.004-0.009,0.006-0.014c4.654-11.225,13.848-19.949,25.297-24.021 L462,283.742z M256,331.546c-41.724,0-75.548-33.823-75.548-75.546s33.824-75.547,75.548-75.547 c41.723,0,75.546,33.824,75.546,75.547S297.723,331.546,256,331.546z"></path></svg></a><a id="jr-fip-sw" class="btn wsprkl hidden" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-rtoc-sw" class="btn wsprkl hidden" title="Table of Contents"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,20h10v8H20V20zM36,20h44v8H36V20zM20,37.33h10v8H20V37.33zM36,37.33h44v8H36V37.33zM20,54.66h10v8H20V54.66zM36,54.66h44v8H36V54.66zM20,72h10v8 H20V72zM36,72h44v8H36V72z"></path></svg></a></div></div></nav><nav id="jr-dash" class="noselect"><nav id="jr-dash" class="noselect"><div id="jr-pi" class="hidden"><a id="jr-pi-prev" class="hidden" title="Previous page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a><div class="pginfo">Page <i class="jr-pg-pn">0</i> of <i class="jr-pg-lp">0</i></div><a id="jr-pi-next" class="hidden" title="Next page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div><div id="jr-is-tb"><a id="jr-is-sw" class="btn wsprkl hidden" title="Switch between Figures/Tables strip and Progress bar"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><rect x="10" y="40" width="20" height="20"></rect><rect x="40" y="40" width="20" height="20"></rect><rect x="70" y="40" width="20" height="20"></rect></svg></a></div><nav id="jr-istrip" class="istrip hidden"><a id="jr-is-prev" href="#" class="hidden" title="Previous"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M80,40 60,65 80,90 70,90 50,65 70,40z M50,40 30,65 50,90 40,90 20,65 40,40z"></path><text x="35" y="25" textLength="60" style="font-size:25px">Prev</text></svg></a><a id="jr-is-next" href="#" class="hidden" title="Next"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,40 40,65 20,90 30,90 50,65 30,40z M50,40 70,65 50,90 60,90 80,65 60,40z"></path><text x="15" y="25" textLength="60" style="font-size:25px">Next</text></svg></a></nav><nav id="jr-progress"></nav></nav></nav><aside id="jr-links-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">NCBI Bookshelf</div></div><div class="cnt lol f1"><a href="/books/">Home</a><a href="/books/browse/">Browse All Titles</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/sharer/sharer.php?u=https://www.ncbi.nlm.nih.gov/books/NBK385288/"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24" preserveAspectRatio="none"><g><path d="M 17.996,32L 12,32 L 12,16 l-4,0 l0-5.514 l 4-0.002l-0.006-3.248C 11.993,2.737, 13.213,0, 18.512,0l 4.412,0 l0,5.515 l-2.757,0 c-2.063,0-2.163,0.77-2.163,2.209l-0.008,2.76l 4.959,0 l-0.585,5.514L 18,16L 17.996,32z"></path></g></svg> Share on Facebook</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://twitter.com/intent/tweet?url=https://www.ncbi.nlm.nih.gov/books/NBK385288/&text=Aripiprazole%20Therapy%20and%20CYP2D6%20Genotype"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24"><g><path d="M 32,6.076c-1.177,0.522-2.443,0.875-3.771,1.034c 1.355-0.813, 2.396-2.099, 2.887-3.632 c-1.269,0.752-2.674,1.299-4.169,1.593c-1.198-1.276-2.904-2.073-4.792-2.073c-3.626,0-6.565,2.939-6.565,6.565 c0,0.515, 0.058,1.016, 0.17,1.496c-5.456-0.274-10.294-2.888-13.532-6.86c-0.565,0.97-0.889,2.097-0.889,3.301 c0,2.278, 1.159,4.287, 2.921,5.465c-1.076-0.034-2.088-0.329-2.974-0.821c-0.001,0.027-0.001,0.055-0.001,0.083 c0,3.181, 2.263,5.834, 5.266,6.438c-0.551,0.15-1.131,0.23-1.73,0.23c-0.423,0-0.834-0.041-1.235-0.118 c 0.836,2.608, 3.26,4.506, 6.133,4.559c-2.247,1.761-5.078,2.81-8.154,2.81c-0.53,0-1.052-0.031-1.566-0.092 c 2.905,1.863, 6.356,2.95, 10.064,2.95c 12.076,0, 18.679-10.004, 18.679-18.68c0-0.285-0.006-0.568-0.019-0.849 C 30.007,8.548, 31.12,7.392, 32,6.076z"></path></g></svg> Share on Twitter</a></div></aside><aside id="jr-rtoc-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Table of Content</div></div><div class="cnt lol f1"><a href="/books/n/gtrbook/?report=reader">Title Information</a><a href="/books/n/gtrbook/toc/?report=reader">Table of Contents Page</a></div></aside><aside id="jr-help-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Settings</div></div><div class="cnt f1"><div id="jr-typo-p" class="typo"><div><a class="sf btn wsprkl">A-</a><a class="lf btn wsprkl">A+</a></div><div><a class="bcol-auto btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 200 100" preserveAspectRatio="none"><text x="10" y="70" style="font-size:60px;font-family: Trebuchet MS, ArialMT, Arial, sans-serif" textLength="180">AUTO</text></svg></a><a class="bcol-1 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M15,25 85,25zM15,40 85,40zM15,55 85,55zM15,70 85,70z"></path></svg></a><a class="bcol-2 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M5,25 45,25z M55,25 95,25zM5,40 45,40z M55,40 95,40zM5,55 45,55z M55,55 95,55zM5,70 45,70z M55,70 95,70z"></path></svg></a></div></div><div class="lol"><a class="" href="/books/NBK385288/?report=classic">Switch to classic view</a><a href="/books/NBK385288/pdf/Bookshelf_NBK385288.pdf">PDF (272K)</a><a href="/books/n/gtrbook/pdf/">PDF (11M)</a><a href="/books/NBK385288/?report=printable">Print View</a></div></div></aside><aside id="jr-bkhelp-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Help</div></div><div class="cnt f1 lol"><a id="jr-helpobj-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/help.xml" href="">Help</a><a href="mailto:info@ncbi.nlm.nih.gov?subject=PubReader%20feedback%20%2F%20NBK385288%20%2F%20sid%3ACE8B5AF87C7FFCB1_0191SID%20%2F%20phid%3ACE8EF32E7D5B9041000000000058004B.4">Send us feedback</a><a id="jr-about-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/about.xml" href="">About PubReader</a></div></aside><aside id="jr-objectbox" class="thidden hidden"><div class="jr-objectbox-close wsprkl">✘</div><div class="jr-objectbox-inner cnt"><div class="jr-objectbox-drawer"></div></div></aside><nav id="jr-pm-left" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Previous Page</text></svg></nav><nav id="jr-pm-right" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Next Page</text></svg></nav><nav id="jr-fip" class="hidden"><nav id="jr-fip-term-p"><input type="search" placeholder="search this page" id="jr-fip-term" autocorrect="off" autocomplete="off" /><a id="jr-fip-mg" class="wsprkl btn" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-fip-done" class="wsprkl btn" title="Dismiss find">✘</a></nav><nav id="jr-fip-info-p"><a id="jr-fip-prev" class="wsprkl btn" title="Jump to previuos match">◀</a><button id="jr-fip-matches">no matches yet</button><a id="jr-fip-next" class="wsprkl btn" title="Jump to next match">▶</a></nav></nav></div><div id="jr-epub-interstitial" class="hidden"></div><div id="jr-content"><article data-type="main"><div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><div class="fm-sec"><h1 id="_NBK385288_"><span class="title" itemprop="name">Aripiprazole Therapy and <i>CYP2D6</i> Genotype</span></h1><p class="contribs">Dean L, Kane M.</p><p class="fm-aai"><a href="#_NBK385288_pubdet_">Publication Details</a></p><p><em>Estimated reading time: 20 minutes</em></p></div></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="aripiprazole.Introduction" itemprop="description"><h2 id="_aripiprazole_Introduction_">Introduction</h2><p>Aripiprazole (brand names Abilify or Aristada) is an atypical antipsychotic used to manage schizophrenia, bipolar disorder, major depressive disorder, irritability associated with autistic disorder, and in the treatment of Tourette syndrome. (<a class="bibr" href="#aripiprazole.REF.1" rid="aripiprazole.REF.1">1</a>)</p><p>The metabolism and elimination of aripiprazole is mainly mediated through 2 enzymes, CYP2D6 and CYP3A4. Approximately 8% of Caucasians, 3–8% of Black/African Americans and up to 2% of Asians cannot metabolize CYP2D6 substrates and are classified as “poor metabolizers.” (<a class="bibr" href="#aripiprazole.REF.2" rid="aripiprazole.REF.2">2</a>)</p><p>The FDA-approved drug label for aripiprazole states that in CYP2D6 poor metabolizers, half of the usual dose should be administered. In CYP2D6 poor metabolizers who are taking concomitant strong CYP3A4 inhibitors (for example, itraconazole, clarithromycin), a quarter of the usual dose should be used (<a href="/books/NBK385288/table/aripiprazole.T.the_fda_dosing_recommenda/?report=objectonly" target="object" rid-ob="figobaripiprazoleTthefdadosingrecommenda">Table 1</a>) (<a class="bibr" href="#aripiprazole.REF.1" rid="aripiprazole.REF.1">1</a>). The dosage reduction is the same regardless of the administration route (oral or long-acting injectable). (<a class="bibr" href="#aripiprazole.REF.3" rid="aripiprazole.REF.3">3</a>)</p><p>The Dutch Pharmacogenetics Working group (DPWG) also recommends a reduced dosage for CYP2D6 poor metabolizers, “no more than 10 mg/day or 300 mg/month” (<a href="/books/NBK385288/table/aripiprazole.T.the_dpwg_dosing_recommend/?report=objectonly" target="object" rid-ob="figobaripiprazoleTthedpwgdosingrecommend">Table 2</a>). No action is recommended for intermediate or ultrarapid metabolizers. While both of these metabolic variations alter the plasma concentrations of aripiprazole, there is no evidence that this increases the risk of reduced effectiveness or risk of side effects. (<a class="bibr" href="#aripiprazole.REF.4" rid="aripiprazole.REF.4">4</a>)</p><p>In contrast to the recommendations by the FDA and DPWG, some recent studies have suggested CYP2D6 intermediate metabolizers may also require a dose decrease, but this was only based on aripiprazole clearance. (<a class="bibr" href="#aripiprazole.REF.5" rid="aripiprazole.REF.5">5</a>, <a class="bibr" href="#aripiprazole.REF.6" rid="aripiprazole.REF.6">6</a>, <a class="bibr" href="#aripiprazole.REF.7" rid="aripiprazole.REF.7">7</a>, <a class="bibr" href="#aripiprazole.REF.8" rid="aripiprazole.REF.8">8</a>)</p></div><div class="h2"></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figaripiprazoleTthefdadosingrecommenda"><a href="/books/NBK385288/table/aripiprazole.T.the_fda_dosing_recommenda/?report=objectonly" target="object" title="Table 1. " class="img_link icnblk_img" rid-ob="figobaripiprazoleTthefdadosingrecommenda"><img class="small-thumb" src="/corehtml/pmc/css/bookshelf/2.26/img/table-icon.gif" alt="Table Icon" /></a><div class="icnblk_cntnt"><h4 id="aripiprazole.T.the_fda_dosing_recommenda"><a href="/books/NBK385288/table/aripiprazole.T.the_fda_dosing_recommenda/?report=objectonly" target="object" rid-ob="figobaripiprazoleTthefdadosingrecommenda">Table 1. </a></h4><p class="float-caption no_bottom_margin">The FDA Dosing Recommendations for Aripiprazole and CYP2D6 Metabolizer Status and Comedications (2020) </p></div></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figaripiprazoleTthedpwgdosingrecommend"><a href="/books/NBK385288/table/aripiprazole.T.the_dpwg_dosing_recommend/?report=objectonly" target="object" title="Table 2. " class="img_link icnblk_img" rid-ob="figobaripiprazoleTthedpwgdosingrecommend"><img class="small-thumb" src="/corehtml/pmc/css/bookshelf/2.26/img/table-icon.gif" alt="Table Icon" /></a><div class="icnblk_cntnt"><h4 id="aripiprazole.T.the_dpwg_dosing_recommend"><a href="/books/NBK385288/table/aripiprazole.T.the_dpwg_dosing_recommend/?report=objectonly" target="object" rid-ob="figobaripiprazoleTthedpwgdosingrecommend">Table 2. </a></h4><p class="float-caption no_bottom_margin">The DPWG Dosing Recommendations for Aripiprazole and CYP2D6 Metabolizer Status (2018) </p></div></div><div id="aripiprazole.Drug_Aripiprazole"><h2 id="_aripiprazole_Drug_Aripiprazole_">Drug: Aripiprazole</h2><p>Aripiprazole is an atypical antipsychotic primarily used to treat schizophrenia and bipolar disorder. Aripiprazole may also be used as part of the management of major depressive disorder, irritability associated with autism, and in the treatment of Tourette syndrome. (<a class="bibr" href="#aripiprazole.REF.1" rid="aripiprazole.REF.1">1</a>, <a class="bibr" href="#aripiprazole.REF.3" rid="aripiprazole.REF.3">3</a>)</p><p>The first antipsychotics to be discovered in the 1950s were haloperidol and chlorpromazine. Known as “first-generation” or “typical” antipsychotics, these drugs are used to treat psychosis (regardless of the cause), chronic psychotic disorders (for example, schizophrenia), and other psychiatric conditions. However, prominent adverse effects included extrapyramidal side effects such as tardive dyskinesia, muscle rigidity, tremors, and Parkinsonian-like symptoms.</p><p>Newer antipsychotics, known as “second generation” or “atypical” antipsychotics, have a lower risk of extrapyramidal side effects such as tardive dyskinesia. However, many have serious metabolic effects. Aripiprazole is an atypical antipsychotic that is noted for having fewer metabolic side effects than other atypicals, such as clozapine, olanzapine, risperidone, and quetiapine. Other atypicals approved by the FDA include asenapine, brexpiprazole, cariprazine, lurasidone, paliperidone, and ziprasidone.</p><p>The main action of both first-generation and second-generation antipsychotics is thought to be the post-synaptic blockade of D2 dopamine receptors. All antipsychotics, with the exception of aripiprazole, are D2 antagonists.</p><p>Aripiprazole is a partial D2 agonist. Aripiprazole binds to the D2 receptor with a high affinity similar to dopamine. However, because it has low intrinsic activity, it causes much lower activation of the receptor compared with dopamine.</p><p>The combination of a high affinity for the D2 receptor and its partial agonist activity may result in aripiprazole reducing the high-frequency firing of dopamine neurons in the brain’s mesolimbic system. Overactivity in this region is thought to underlie psychosis and other positive symptoms of schizophrenia. In addition, the preservation of some D2 receptor activity in other dopamine-rich pathways in the brain (mesocortical and nigrostriatal areas) may provide more protection against extrapyramidal side effects. (<a class="bibr" href="#aripiprazole.REF.10" rid="aripiprazole.REF.10">10</a>, <a class="bibr" href="#aripiprazole.REF.11" rid="aripiprazole.REF.11">11</a>)</p><p>Aripiprazole also has a high affinity for the serotonin 5-HT<sub>2A</sub> receptors, where it acts as an antagonist and it moderately blocks the alpha 1 adrenergic and histamine H1 receptors, which may account for the lower incidence of orthostatic hypotension and sedation compared with other antipsychotics. (<a class="bibr" href="#aripiprazole.REF.12" rid="aripiprazole.REF.12">12</a>)</p><p>Adverse events with aripiprazole therapy include increased mortality in elderly individuals with psychosis caused by dementia, suicidal thoughts and behavior in children and young adults, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes including hyperglycemia, pathological gambling, and other compulsive behaviors. Additionally, orthostatic hypotension, leukopenia, neutropenia, and agranulocytosis, seizures/convulsions and potential cognitive and motor impairment have been reported. Commonly observed adverse reactions in adult schizophrenic individuals that should be reported to the FDA include akathisia. Adverse events in pediatric individuals (13–17 years old) that should be reported are extrapyramidal disorder, somnolence, and tremor. (<a class="bibr" href="#aripiprazole.REF.1" rid="aripiprazole.REF.1">1</a>)</p><p>Aripiprazole is extensively metabolized in the liver by the cytochrome P450 (CYP) superfamily of enzymes, mainly CYP2D6 and CYP3A4. Aripiprazole activity is thought to be primarily due to the parent drug, and to a lesser extent its major metabolite, dehydroaripiprazole. The mean elimination half-life is approximately 75 hours for aripiprazole, but in individuals who have no appreciable CYP2D6 activity (poor metabolizers), the mean elimination half-life for aripiprazole is around 146 hours. (<a class="bibr" href="#aripiprazole.REF.1" rid="aripiprazole.REF.1">1</a>) The mean aripiprazole exposure for CYP2D6 poor and intermediate metabolizers is increased 1.5-fold compared with normal metabolizers (<a class="bibr" href="#aripiprazole.REF.6" rid="aripiprazole.REF.6">6</a>).</p><p>While aripiprazole has been reported to have a minimal effect on prolactin levels (<a class="bibr" href="#aripiprazole.REF.13" rid="aripiprazole.REF.13">13</a>), more recent studies have found a correlation between reduced CYP2D6 enzyme activity and increases in prolactin. (<a class="bibr" href="#aripiprazole.REF.14" rid="aripiprazole.REF.14">14</a>, <a class="bibr" href="#aripiprazole.REF.15" rid="aripiprazole.REF.15">15</a>) These increases in prolactin levels were more pronounced in females and individuals with no functional CYP2D6, raising the possibility of a higher risk for hyperprolactinemia adverse reactions. Hyperprolactinemia can have significant effect in the pediatric population during growth and development and may warrant additional monitoring. (<a class="bibr" href="#aripiprazole.REF.14" rid="aripiprazole.REF.14">14</a>)</p><p>Rare cardiac adverse reactions have also been observed in clinical trials with aripiprazole. (<a class="bibr" href="#aripiprazole.REF.3" rid="aripiprazole.REF.3">3</a>) Two recent case reports suggest that CYP2D6 activity may play a role in predisposing an individual to atrial fibrillation or abnormal heart electrophysiology. (<a class="bibr" href="#aripiprazole.REF.16" rid="aripiprazole.REF.16">16</a>, <a class="bibr" href="#aripiprazole.REF.17" rid="aripiprazole.REF.17">17</a>) One small study reported that palpitations were more commonly experienced by females versus males taking aripiprazole and more often with aripiprazole versus olanzapine treatment. (<a class="bibr" href="#aripiprazole.REF.18" rid="aripiprazole.REF.18">18</a>)</p><p>The FDA-approved drug label warns that “neonates exposed to antipsychotic drugs, including aripiprazole, during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery.” (<a class="bibr" href="#aripiprazole.REF.1" rid="aripiprazole.REF.1">1</a>) These exposures should be considered in light of the disease-associated maternal or embryo/fetal, or both, risks of untreated schizophrenia or bipolar I disorder. The FDA-approved label states that neonates who are exposed to aripiprazole during pregnancy should be closely monitored, as symptoms vary in severity and duration (hours to days) and may require prolonged hospitalization. The FDA encourages healthcare providers to register individuals who have aripiprazole exposure while pregnant to monitor pregnancy outcomes. For more information see (<a class="bibr" href="#aripiprazole.REF.1" rid="aripiprazole.REF.1">1</a>, <a class="bibr" href="#aripiprazole.REF.3" rid="aripiprazole.REF.3">3</a>).</p><p>Limited data from scientific literature suggests a low level of aripiprazole can be present in breast milk. The literature reports the relative infant dose ranges between 0.7% and 8.3% of the maternal weight-adjusted dosage. (<a class="bibr" href="#aripiprazole.REF.1" rid="aripiprazole.REF.1">1</a>) Though aripiprazole has a minimal effect on prolactin levels compared with the phenothiazines, case reports have documented both decreased lactation and hyperprolactinemia in nursing mothers taking aripiprazole, and other medications may be considered, as needed. (<a class="bibr" href="#aripiprazole.REF.19" rid="aripiprazole.REF.19">19</a>)</p></div><div id="aripiprazole.Gene_CYP2D6"><h2 id="_aripiprazole_Gene_CYP2D6_">Gene: <i>CYP2D6</i></h2><p>The cytochrome P450 superfamily (CYP450) is a large and diverse group of enzymes that form the major system for metabolizing lipids, hormones, toxins, and drugs in the liver. The <i>CYP450</i> genes are very polymorphic and can result in decreased, absent, or increased enzyme activity.</p><p>The CYP2D6 enzyme is responsible for the metabolism of many commonly prescribed drugs, including antidepressants, antipsychotics, analgesics, and beta-blockers.</p><div id="aripiprazole.CYP2D6_Alleles"><h3><i>CYP2D6</i> Alleles</h3><p>The <i>CYP2D6</i> gene is highly polymorphic, as over 100 star (*) alleles have been described and cataloged at the Pharmacogene Variation (PharmVar) Consortium, and each allele is associated with either normal, decreased, or absent enzyme function (<a href="/books/NBK385288/table/aripiprazole.T.activity_status_of_select/?report=objectonly" target="object" rid-ob="figobaripiprazoleTactivitystatusofselect">Table 3</a>) (<a class="bibr" href="#aripiprazole.REF.20" rid="aripiprazole.REF.20">20</a>). The combination of <i>CYP2D6</i> alleles that a person has is used to determine their diplotype (for example, <i>CYP2D6*4/*4</i>). Based on function, each allele can be assigned an activity score from 0 to 1, which in turn is often used to assign a phenotype (for example, CYP2D6 poor metabolizer). When duplicated alleles are detected, both copies are assigned an activity score for phenotyping. However, the activity score system is not standardized across clinical laboratories or CYP2D6 genotyping platforms. CPIC revised their activity scoring guidelines in October 2019 to promote harmonization. The CYP2D6 phenotype is defined by the sum of the allele activity scores, which is usually in the range of 0–3.0: (<a class="bibr" href="#aripiprazole.REF.21" rid="aripiprazole.REF.21">21</a>)</p><ul><li class="half_rhythm"><div>An ultrarapid metabolizer (UM) has an activity score greater than 2.25</div></li><li class="half_rhythm"><div>A normal metabolizer phenotype (NM) has an activity score of 1.25 to 2.25</div></li><li class="half_rhythm"><div>An intermediate metabolizer (IM) has an activity score of >0 to 1.25</div></li><li class="half_rhythm"><div>A poor metabolizer (PM) has an activity score of 0</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figaripiprazoleTactivitystatusofselect"><a href="/books/NBK385288/table/aripiprazole.T.activity_status_of_select/?report=objectonly" target="object" title="Table 3. " class="img_link icnblk_img" rid-ob="figobaripiprazoleTactivitystatusofselect"><img class="small-thumb" src="/corehtml/pmc/css/bookshelf/2.26/img/table-icon.gif" alt="Table Icon" /></a><div class="icnblk_cntnt"><h4 id="aripiprazole.T.activity_status_of_select"><a href="/books/NBK385288/table/aripiprazole.T.activity_status_of_select/?report=objectonly" target="object" rid-ob="figobaripiprazoleTactivitystatusofselect">Table 3. </a></h4><p class="float-caption no_bottom_margin">Activity Status of Selected CYP2D6 Alleles </p></div></div><p>The
|
|
<i>CYP2D6*1</i> allele is considered the wild-type allele when no variants are detected and is associated with normal enzyme activity and the “normal metabolizer” phenotype. In addition, the <i>CYP2D6*2</i>, <i>*27</i>, and *<i>33</i> alleles are also considered to have near-normal activity.</p><p>Other <i>CYP2D6</i> alleles include variants that produce a non-functioning enzyme (for example, <i>*3</i>, <i>*4</i>, <i>*5,</i> and <i>*6</i>) (<a class="bibr" href="#aripiprazole.REF.23" rid="aripiprazole.REF.23">23</a>, <a class="bibr" href="#aripiprazole.REF.24" rid="aripiprazole.REF.24">24</a>, <a class="bibr" href="#aripiprazole.REF.25" rid="aripiprazole.REF.25">25</a>) or an enzyme with decreased activity (for example, <i>*10</i>, <i>*17</i>, and <i>*41</i>) (<a class="bibr" href="#aripiprazole.REF.26" rid="aripiprazole.REF.26">26</a>, <a class="bibr" href="#aripiprazole.REF.27" rid="aripiprazole.REF.27">27</a>, <a class="bibr" href="#aripiprazole.REF.28" rid="aripiprazole.REF.28">28</a>) (see <a href="/books/NBK385288/table/aripiprazole.T.activity_status_of_select/?report=objectonly" target="object" rid-ob="figobaripiprazoleTactivitystatusofselect">Table 3</a>). There are large inter-ethnic differences in the frequency of these alleles, with <i>*3</i>, <i>*4</i>, <i>*5</i>, <i>*6,</i> and <i>*41</i> being more common in Caucasians, <i>*17</i> more common in Africans, and <i>*10</i> more common in Asians. (<a class="bibr" href="#aripiprazole.REF.29" rid="aripiprazole.REF.29">29</a>, <a class="bibr" href="#aripiprazole.REF.30" rid="aripiprazole.REF.30">30</a>)</p><p>
|
|
<b>Allele Frequencies Vary between Populations</b>
|
|
</p><p>Among Asians and in individuals of Asian descent, only approximately 50% of <i>CYP2D6</i> alleles are normal function, and the frequency of <i>CYP2D6</i> duplications is as high as 45%, although this may have been overestimated by not accounting for tandem hybrid alleles (for example, <i>*36+*10</i>) (<a class="bibr" href="#aripiprazole.REF.31" rid="aripiprazole.REF.31">31</a>). Other studies of a US individual population suggested less than 50% of alleles detected within Asian-descent individuals are normal-function alleles in a single copy, with 30% of alleles arising from structural variants (duplications or deletions) (<a class="bibr" href="#aripiprazole.REF.32" rid="aripiprazole.REF.32">32</a>). Common no-function variants are <i>CYP2D6*36</i> and <i>CYP2D6*4</i> (<a class="bibr" href="#aripiprazole.REF.32" rid="aripiprazole.REF.32">32</a>). Both these alleles contain the variant “c.100C>T” (see Allele Nomenclature table) (<a class="bibr" href="#aripiprazole.REF.29" rid="aripiprazole.REF.29">29</a>, <a class="bibr" href="#aripiprazole.REF.31" rid="aripiprazole.REF.31">31</a>, <a class="bibr" href="#aripiprazole.REF.33" rid="aripiprazole.REF.33">33</a>, <a class="bibr" href="#aripiprazole.REF.34" rid="aripiprazole.REF.34">34</a>). The <i>CYP2D6*36</i> allele is the result of a gene conversion event with the pseudogene <i>CYP2D7</i> (<a class="bibr" href="#aripiprazole.REF.35" rid="aripiprazole.REF.35">35</a>). This no-function allele is most commonly found in individuals of Asian ancestry (<a class="bibr" href="#aripiprazole.REF.32" rid="aripiprazole.REF.32">32</a>).</p><p>Among Africans and African Americans, only approximately 50% of <i>CYP2D6</i> alleles are normal function (<a class="bibr" href="#aripiprazole.REF.23" rid="aripiprazole.REF.23">23</a>, <a class="bibr" href="#aripiprazole.REF.28" rid="aripiprazole.REF.28">28</a>, <a class="bibr" href="#aripiprazole.REF.29" rid="aripiprazole.REF.29">29</a>, <a class="bibr" href="#aripiprazole.REF.36" rid="aripiprazole.REF.36">36</a>). African Americans also have been found to have a higher frequency of no-function structural variants or decreased-function single-copy variant alleles versus Caucasian or Hispanic Americans (<a class="bibr" href="#aripiprazole.REF.32" rid="aripiprazole.REF.32">32</a>).</p><p>Middle Eastern countries show a great diversity in phenotypic and allelic distribution for <i>CYP2D6</i> (<a class="bibr" href="#aripiprazole.REF.37" rid="aripiprazole.REF.37">37</a>), though on average, these individuals show a lower frequency of poor metabolizer phenotypes (0.91%) and higher ultrarapid phenotypes (11.2%) than other ethnicities (Note: Oceania and Middle Eastern ethnicities combined in this study) (<a class="bibr" href="#aripiprazole.REF.2" rid="aripiprazole.REF.2">2</a>).</p><p>Among European countries, there is diversity of allelic distribution (<a class="bibr" href="#aripiprazole.REF.38" rid="aripiprazole.REF.38">38</a>). Gene duplications were more common in the south-eastern countries (Greece, Turkey: 6%) and less common in north-western countries (Sweden and Denmark, <1%). Meanwhile, <i>CYP2D6*4</i> and <i>*5</i> alleles were generally more common in the north and less common in the south. (<a class="bibr" href="#aripiprazole.REF.38" rid="aripiprazole.REF.38">38</a>) Worldwide <i>CYP2D6</i> genotype and phenotype frequencies have been catalogued and recently published (<a class="bibr" href="#aripiprazole.REF.2" rid="aripiprazole.REF.2">2</a>).</p></div><div id="aripiprazole.CYP2D6_Phenotype"><h3><i>CYP2D6</i> Phenotype</h3><p>
|
|
<b><i>CYP2D6</i> Phenotype Frequencies Vary between Populations</b>
|
|
</p><p>Normal metabolizers: Approximately 77–92% of individuals have 2 normal-function alleles (<i>*1</i> or <i>*2</i>), or one normal-function allele and one decreased-function allele. These individuals are “normal metabolizers” and are most likely to have a phenotypically normal response to the drug.</p><p>Intermediate metabolizers: Approximately 2–11% of individuals are intermediate metabolizers—they have either 2 decreased-function alleles or one normal- or decreased-function and one no-function allele (<a class="bibr" href="#aripiprazole.REF.2" rid="aripiprazole.REF.2">2</a>). A study of a diverse US urban population of children found that roughly 8% of subjects were intermediate metabolizers (<a class="bibr" href="#aripiprazole.REF.39" rid="aripiprazole.REF.39">39</a>), Within the US, it has been observed that individuals of African or Asian descent were most likely to be classified as intermediate metabolizers (20–28% of population by ethnicity) (<a class="bibr" href="#aripiprazole.REF.32" rid="aripiprazole.REF.32">32</a>).</p><p>Poor metabolizers: Approximately 5–10% of individuals are poor metabolizers—they have 2 no-function alleles (<a class="bibr" href="#aripiprazole.REF.40" rid="aripiprazole.REF.40">40</a>). Poor metabolizers are more commonly found in European Caucasians and their descendants. The no-function <i>CYP2D6*4</i> and <i>*5</i> alleles largely account for the poor metabolizer phenotype in these populations (<a class="bibr" href="#aripiprazole.REF.27" rid="aripiprazole.REF.27">27</a>, <a class="bibr" href="#aripiprazole.REF.41" rid="aripiprazole.REF.41">41</a>, <a class="bibr" href="#aripiprazole.REF.42" rid="aripiprazole.REF.42">42</a>). It should be noted that the frequency of poor metabolizers can be much lower in certain populations including East Asian, Oceania and Middle Eastern (<a class="bibr" href="#aripiprazole.REF.2" rid="aripiprazole.REF.2">2</a>). Studies of US multi-ethnic populations have estimated the prevalence of poor metabolizers to be between 1.5–5.7% (<a class="bibr" href="#aripiprazole.REF.32" rid="aripiprazole.REF.32">32</a>, <a class="bibr" href="#aripiprazole.REF.39" rid="aripiprazole.REF.39">39</a>).</p><p>Ultrarapid metabolizers: Individuals who are ultrarapid metabolizers have at least 3 copies of the <i>CYP2D6</i> gene. The ultrarapid metabolizer phenotype has been estimated to be present in 1–2% of individuals, but the prevalence varies widely in different populations. It is estimated to be present in up to 28% of North Africans, Ethiopians, and Arabs; up to 10% in Caucasians; 3% in African Americans, and up to 1% in Hispanics, Chinese, and Japanese (<a class="bibr" href="#aripiprazole.REF.40" rid="aripiprazole.REF.40">40</a>, <a class="bibr" href="#aripiprazole.REF.43" rid="aripiprazole.REF.43">43</a>). Ultrarapid metabolizers made up 9% of subjects in an urban multi-ethnic population with a large portion of Hispanic/Latino subjects (<a class="bibr" href="#aripiprazole.REF.39" rid="aripiprazole.REF.39">39</a>). A larger study of US individuals predicted an ultrarapid metabolizer phenotype in only 2.2% of individuals, regardless of ethnicity (<a class="bibr" href="#aripiprazole.REF.32" rid="aripiprazole.REF.32">32</a>).</p></div></div><div id="aripiprazole.Linking_Gene_Variation_with"><h2 id="_aripiprazole_Linking_Gene_Variation_with_">Linking Gene Variation with Treatment Response</h2><p>Genetic variations in the <i>CYP2D6</i> gene have been found to impact serum levels of aripiprazole and dehydroaripiprazole. (<a class="bibr" href="#aripiprazole.REF.8" rid="aripiprazole.REF.8">8</a>, <a class="bibr" href="#aripiprazole.REF.44" rid="aripiprazole.REF.44">44</a>, <a class="bibr" href="#aripiprazole.REF.45" rid="aripiprazole.REF.45">45</a>) Because standard doses of aripiprazole lead to higher plasma levels of aripiprazole and dehydroaripiprazole, the dose of aripiprazole should be adjusted for individuals that have 2 no-function <i>CYP2D6</i> alleles causing poor metabolizer status.</p><p>The FDA recommends that individuals who are known to be CYP2D6 poor metabolizers should receive half the standard dose of aripiprazole, or a quarter of the standard dose if they are also taking medicines that strongly inhibit CYP3A4 (for example, itraconazole, clarithromycin) (see <a href="/books/NBK385288/table/aripiprazole.T.the_fda_dosing_recommenda/?report=objectonly" target="object" rid-ob="figobaripiprazoleTthefdadosingrecommenda">Table 1</a>). Multiple studies substantiate the FDA recommendations by concluding that poor metabolizers should receive a reduced dose of aripiprazole (30–50% reduction). (<a class="bibr" href="#aripiprazole.REF.5" rid="aripiprazole.REF.5">5</a>, <a class="bibr" href="#aripiprazole.REF.6" rid="aripiprazole.REF.6">6</a>, <a class="bibr" href="#aripiprazole.REF.8" rid="aripiprazole.REF.8">8</a>, <a class="bibr" href="#aripiprazole.REF.45" rid="aripiprazole.REF.45">45</a>, <a class="bibr" href="#aripiprazole.REF.46" rid="aripiprazole.REF.46">46</a>)</p><p>One study further suggested that individuals with increased CYP2D6 activity (ultrarapid metabolizers) may need to take an alternative antipsychotic not metabolized by CYP2D6 because of reduced drug levels. (<a class="bibr" href="#aripiprazole.REF.46" rid="aripiprazole.REF.46">46</a>) Additional studies have suggested that intermediate metabolizers should also have a reduced dosage, in contrast with the current FDA-approved drug labeling. (<a class="bibr" href="#aripiprazole.REF.5" rid="aripiprazole.REF.5">5</a>, <a class="bibr" href="#aripiprazole.REF.6" rid="aripiprazole.REF.6">6</a>, <a class="bibr" href="#aripiprazole.REF.7" rid="aripiprazole.REF.7">7</a>, <a class="bibr" href="#aripiprazole.REF.47" rid="aripiprazole.REF.47">47</a>) This is particularly relevant among individuals of Asian descent, where the intermediate metabolizer phenotype is highly prevalent. (<a class="bibr" href="#aripiprazole.REF.7" rid="aripiprazole.REF.7">7</a>) One study reported that females and poor metabolizers are at an elevated risk for adverse events. (<a class="bibr" href="#aripiprazole.REF.8" rid="aripiprazole.REF.8">8</a>)</p><p>Phenoconversion from a CYP2D6 normal metabolizer status to reduced metabolic activity has also been suggested due to drug-drug interactions in individuals with one or more wild-type <i>CYP2D6*1</i> allele. (<a class="bibr" href="#aripiprazole.REF.47" rid="aripiprazole.REF.47">47</a>) The drugs observed by this study to have an effect on CYP2D6 activity were risperidone, metoprolol and propranolol. (<a class="bibr" href="#aripiprazole.REF.47" rid="aripiprazole.REF.47">47</a>) Additionally, phenoconversion has been associated with a higher rate of aripiprazole discontinuation (<a class="bibr" href="#aripiprazole.REF.48" rid="aripiprazole.REF.48">48</a>). Aripiprazole can lead to drug-drug interactions with other CYP2D6 substrates, particularly those with weaker affinity for the CYP2D6 enzyme—for example, the antidepressant mirtazapine—resulting in an increase in plasma concentration for the co-medication (<a class="bibr" href="#aripiprazole.REF.49" rid="aripiprazole.REF.49">49</a>). The FDA drug label recommends reducing the aripiprazole dosage with concomitant use of strong CYP2D6 inhibitors (for example quinidine, fluoxetine and paroxetine) or CYP3A4 inhibitors. (<a class="bibr" href="#aripiprazole.REF.1" rid="aripiprazole.REF.1">1</a>)</p></div><div id="aripiprazole.Genetic_Testing"><h2 id="_aripiprazole_Genetic_Testing_">Genetic Testing</h2><p>The NIH Genetic Testing Registry provides examples of the genetic tests that are available for <a href="https://www.ncbi.nlm.nih.gov/gtr/conditions/CN077955/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">aripiprazole response</a> and for the <a href="https://www.ncbi.nlm.nih.gov/gtr/all/tests/?term=1565%5Bgeneid%5D" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri"><i>CYP2D6</i> gene</a>.</p><p><i>CYP2D6</i> is a particularly complex gene that is difficult to genotype because of the large number of variants and the presence of gene deletions, duplications, multiplications, and pseudogenes. The complexity of genetic variation complicates making a correct determination of <i>CYP2D6</i> genotype.</p><p>Targeted genotyping typically includes up to 30 variant <i>CYP2D6</i> alleles (over 100 alleles have been identified so far). Test results are reported as a diplotype, such as <i>CYP2D6 *1/*1</i>. However, it is important to note that the number of variants tested can vary among laboratories, which can result in diplotype result discrepancies between testing platforms and laboratories. (<a class="bibr" href="#aripiprazole.REF.50" rid="aripiprazole.REF.50">50</a>)</p><p>A result for copy number, if available, is also important when interpreting <i>CYP2D6</i> genotyping results. Gene duplications and multiplications are denoted by “xN” for example, <i>CYP2D6*1xN</i> with <i>xN</i> representing the number of <i>CYP2D6</i> gene copies. The functional status of the duplicated allele is also critical in interpretation of the test results, as duplication of a no-function versus a normal-function allele would result in a different total activity score and potentially different metabolizer phenotype.</p><p>If the test results include an interpretation of the individual’s predicted metabolizer phenotype, such as “<i>CYP2D6 *1/*1</i>, normal metabolizer”, this can be confirmed by checking the diplotype and assigning an activity score to each allele (for example, 0 for no function, 0.5 for decreased function, and 1.0 for each copy of a normal-function allele, <a href="/books/NBK385288/table/aripiprazole.T.activity_status_of_select/?report=objectonly" target="object" rid-ob="figobaripiprazoleTactivitystatusofselect">Table 3</a>). See the <a href="#aripiprazole.CYP2D6_Alleles"><i>CYP2D6</i> alleles</a> section above for more information.</p></div><div id="aripiprazole.Therapeutic_Recommendations"><h2 id="_aripiprazole_Therapeutic_Recommendations_">Therapeutic Recommendations based on Genotype</h2><p><b>This section contains excerpted</b><sup><a href="#aripiprazole.FN1">1</a></sup>
|
|
<b>information on gene-based dosing recommendations. Neither this section nor other parts of this review contain the complete recommendations from the sources.</b></p><div id="aripiprazole.2020_Statement_from_the_US"><h3>2020 Statement from the US Food and Drug Administration (FDA):</h3><p>Dosage adjustments are recommended in patients who are known CYP2D6 poor metabolizers and in patients taking concomitant CYP3A4 inhibitors or CYP2D6 inhibitors or strong CYP3A4 inducers (see Table 2). When the coadministered drug is withdrawn from the combination therapy, aripiprazole dosage should then be adjusted to its original level. When the coadministered CYP3A4 inducer is withdrawn, aripiprazole dosage should be reduced to the original level over 1 to 2 weeks. Patients who may be receiving a combination of strong, moderate, and weak inhibitors of CYP3A4 and CYP2D6 (e.g., a strong CYP3A4 inhibitor and a moderate CYP2D6 inhibitor or a moderate CYP3A4 inhibitor with a moderate CYP2D6 inhibitor), the dosing may be reduced to one-quarter (25%) of the usual dose initially and then adjusted to achieve a favorable clinical response.</p><p>[…]</p><p>Dosage adjustment is recommended in known CYP2D6 poor metabolizers due to high aripiprazole concentrations. Approximately 8% of Caucasians and 3% to 8% of Black/African Americans cannot metabolize CYP2D6 substrates and are classified as poor metabolizers (PM).</p><p><b>Please review the complete therapeutic recommendations that are located here:(</b><a class="bibr" href="#aripiprazole.REF.1" rid="aripiprazole.REF.1"><b>1</b></a><b>)</b>.</p></div><div id="aripiprazole.2018_Summary_of_recommendat"><h3>2018 Summary of recommendations from the Dutch Pharmacogenetics Working Group (DPWG) of the Royal Dutch Association for the Advancement of Pharmacy (KNMP)</h3><p>
|
|
<b>CYP2D6 PM: aripiprazol [aripiprazole]</b>
|
|
</p><p>The risk of side effects is increased. The genetic variation leads to an increase in the sum of the plasma concentrations of aripiprazole and the active metabolite.</p><p>Administer no more than 10 mg/day or 300 mg/month (67-75% of the standard maximum dose of aripiprazole).</p><p>
|
|
<b>CYP2D6 IM: aripiprazol [aripiprazole]</b>
|
|
</p><p>NO action is needed for this gene-drug interaction.</p><p>The genetic variation increases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is insufficient evidence that this increases the risk of side effects.</p><p>
|
|
<b>CYP2D6 UM: aripiprazol [aripiprazole]</b>
|
|
</p><p>NO action is needed for this gene-drug interaction.</p><p>The genetic variation decreases the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is no evidence that this increases the risk of reduced effectiveness.</p><p><b>Please review the complete therapeutic recommendations that are located here: (</b><a class="bibr" href="#aripiprazole.REF.4" rid="aripiprazole.REF.4"><b>4</b></a><b>)</b>.</p></div></div><div id="aripiprazole.Nomenclature_for_Selected_C"><h2 id="_aripiprazole_Nomenclature_for_Selected_C_">Nomenclature for Selected <i>CYP2D6</i> Alleles</h2><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figaripiprazoleTe"><a href="/books/NBK385288/table/aripiprazole.Te/?report=objectonly" target="object" title="Table" class="img_link icnblk_img" rid-ob="figobaripiprazoleTe"><img class="small-thumb" src="/corehtml/pmc/css/bookshelf/2.26/img/table-icon.gif" alt="Table Icon" /></a><div class="icnblk_cntnt"><h4 id="aripiprazole.Te"><a href="/books/NBK385288/table/aripiprazole.Te/?report=objectonly" target="object" rid-ob="figobaripiprazoleTe">Table</a></h4></div></div></div><div id="aripiprazole.Acknowledgments"><h2 id="_aripiprazole_Acknowledgments_">Acknowledgments</h2><p>2021 Edition (Version 2)</p><p>The authors would like to thank Francisco Abad Santos, MD, PhD, Clinical Pharmacology Department, Hospital Universitario de la Princesa, Madrid, Spain and Marin Jukic, MSc, PhD, Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden for reviewing this summary.</p><p>2016 Edition (Version 1.0)</p><p>The author would like to thank Megan J. Ehret, PharmD, MS, BCPP Behavioral Health Clinical Pharmacy Specialist, Fort Belvoir Community Hospital, Fort Belvoir, VA, USA; Andrea Gaedigk, MS, PhD, Director, Pharmacogenetics Core Laboratory, Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Children's Mercy Hospital, Kansas City, and Professor, School of Medicine, University of Missouri-Kansas City, KS, USA; and Steven Leeder, PharmD, PhD, Marion Merrell Dow/Missouri Endowed Chair in Pediatric Clinical Pharmacology, and Director, Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Children’s Mercy Hospital, Kansas City, KS, USA; for reviewing this summary.</p></div><div id="aripiprazole.Version_History"><h2 id="_aripiprazole_Version_History_">Version History</h2><p>The previous version of this chapter (version 1.0), published September 22, 2016, is available <a href="/books/NBK385288/bin/20160922aripiprazole.pdf">here</a>.</p><p>A minor revision was made (version 2.1) on January 17, 2025. There are no changes to treatment guidelines in the revision; formatting changes and updates to the CYP2D6 nomenclature table to include AMP Tier 1 and Tier 2 allele designations.</p></div><div id="aripiprazole.References"><h2 id="_aripiprazole_References_">References</h2><dl class="temp-labeled-list"><dl class="bkr_refwrap"><dt>1.</dt><dd><div class="bk_ref" id="aripiprazole.REF.1">ARIPIPRAZOLE- aripiprazole tablet [package insert]. Princeton, NJ, USA: Dr.Reddy's Pharmaceutical Inc; 2020. Available from: <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0aa7e178-456a-4942-93aa-9ec18a58939f" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https://dailymed<wbr style="display:inline-block"></wbr>​.nlm<wbr style="display:inline-block"></wbr>​.nih.gov/dailymed/drugInfo<wbr style="display:inline-block"></wbr>​.cfm?setid=0aa7e178-456a-4942-93aa-9ec18a58939f</a>.</div></dd></dl><dl class="bkr_refwrap"><dt>2.</dt><dd><div class="bk_ref" id="aripiprazole.REF.2">Gaedigk, A., K.
|
|
Sangkuhl, M.
|
|
Whirl-Carrillo, T.
|
|
Klein, and J.S.
|
|
Leeder, Prediction of CYP2D6 phenotype from genotype across world populations.
|
|
Genet Med, 2017. 19(1): p. 69-76.
|
|
[<a href="/pmc/articles/PMC5292679/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5292679</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27388693" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27388693</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>3.</dt><dd><div class="bk_ref" id="aripiprazole.REF.3">ABILIFY- aripiprazole tablet, ABILIFY- aripiprazole solution, ABILIFY- aripiprazole tablet orally disintegrating, ABILIFY- aripiprazole injection, solution. Rockville, MD USA: Otsuka America Pharmaceutical Inc.; 2020. Available from: <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https://dailymed<wbr style="display:inline-block"></wbr>​.nlm<wbr style="display:inline-block"></wbr>​.nih.gov/dailymed/drugInfo<wbr style="display:inline-block"></wbr>​.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac</a>.</div></dd></dl><dl class="bkr_refwrap"><dt>4.</dt><dd><div class="bk_ref" id="aripiprazole.REF.4">Royal Dutch Pharmacists Association (KNMP). Dutch Pharmacogenetics Working Group (DPWG). Pharamcogenetic Guidelines [Internet]. Netherlands. CYP2D6 : aripiprazole [Cited July 2020]. Available from <a href="https://www.knmp.nl/patientenzorg/medicatiebewaking/farmacogenetica/pharmacogenetics-1" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https://www<wbr style="display:inline-block"></wbr>​.knmp.nl/patientenzorg<wbr style="display:inline-block"></wbr>​/medicatiebewaking<wbr style="display:inline-block"></wbr>​/farmacogenetica<wbr style="display:inline-block"></wbr>​/pharmacogenetics-1</a>.</div></dd></dl><dl class="bkr_refwrap"><dt>5.</dt><dd><div class="bk_ref" id="aripiprazole.REF.5">Tveito, M., E.
|
|
Molden, G.
|
|
Hoiseth, C.U.
|
|
Correll, and R.L.
|
|
Smith, Impact of age and CYP2D6 genetics on exposure of aripiprazole and dehydroaripiprazole in patients using long-acting injectable versus oral formulation: relevance of poor and intermediate metabolizer status.
|
|
Eur J Clin Pharmacol, 2020. 76(1): p. 41-49.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/31637453" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31637453</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>6.</dt><dd><div class="bk_ref" id="aripiprazole.REF.6">Jukic, M.M., R.L.
|
|
Smith, T.
|
|
Haslemo, E.
|
|
Molden, and M.
|
|
Ingelman-Sundberg, Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study.
|
|
Lancet Psychiatry, 2019. 6(5): p. 418-426.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/31000417" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31000417</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>7.</dt><dd><div class="bk_ref" id="aripiprazole.REF.7">Zhang, X., Q.
|
|
Xiang, X.
|
|
Zhao, L.
|
|
Ma, and Y.
|
|
Cui, Association between aripiprazole pharmacokinetics and CYP2D6 phenotypes: A systematic review and meta-analysis.
|
|
J Clin Pharm Ther, 2019. 44(2): p. 163-173.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/30565279" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30565279</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>8.</dt><dd><div class="bk_ref" id="aripiprazole.REF.8">Belmonte, C., D.
|
|
Ochoa, M.
|
|
Roman, M.
|
|
Saiz-Rodriguez, et al., Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers.
|
|
Basic Clin Pharmacol Toxicol, 2018. 122(6): p. 596-605.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/29325225" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29325225</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>9.</dt><dd><div class="bk_ref" id="aripiprazole.REF.9">Abilify: EPAR - Product Information [Cited 27 Nov 2020]. Available from <a href="https://www.ema.europa.eu/en/medicines/human/EPAR/abilify" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https://www<wbr style="display:inline-block"></wbr>​.ema.europa<wbr style="display:inline-block"></wbr>​.eu/en/medicines/human/EPAR/abilify</a>.</div></dd></dl><dl class="bkr_refwrap"><dt>10.</dt><dd><div class="bk_ref" id="aripiprazole.REF.10">Potkin, S.G., A.R.
|
|
Saha, M.J.
|
|
Kujawa, W.H.
|
|
Carson, et al., Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
|
|
Arch Gen Psychiatry, 2003. 60(7): p. 681-90.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/12860772" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12860772</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>11.</dt><dd><div class="bk_ref" id="aripiprazole.REF.11">Swainston Harrison, T. and C.M.
|
|
Perry, Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
|
|
Drugs, 2004. 64(15): p. 1715-36.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/15257633" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15257633</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>12.</dt><dd><div class="bk_ref" id="aripiprazole.REF.12">Muneer, A., The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic Review.
|
|
Cureus, 2016. 8(4): p. e562.
|
|
[<a href="/pmc/articles/PMC4859817/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4859817</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27190727" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27190727</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>13.</dt><dd><div class="bk_ref" id="aripiprazole.REF.13">Leucht, S., A.
|
|
Cipriani, L.
|
|
Spineli, D.
|
|
Mavridis, et al., Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.
|
|
Lancet, 2013. 382(9896): p. 951-62.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/23810019" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23810019</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>14.</dt><dd><div class="bk_ref" id="aripiprazole.REF.14">Gradinaru, R., N.
|
|
Andreescu, L.
|
|
Nussbaum, L.
|
|
Suciu, and M.
|
|
Puiu, Impact of the CYP2D6 phenotype on hyperprolactinemia development as an adverse event of treatment with atypical antipsychotic agents in pediatric patients.
|
|
Ir J Med Sci, 2019. 188(4): p. 1417-1422.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/30771137" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30771137</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>15.</dt><dd><div class="bk_ref" id="aripiprazole.REF.15">Koller, D., C.
|
|
Belmonte, M.
|
|
Saiz-Rodriguez, P.
|
|
Zubiaur, et al., Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteers.
|
|
Basic Clin Pharmacol Toxicol, 2020. 126(3): p. 236-246.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/31520576" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31520576</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>16.</dt><dd><div class="bk_ref" id="aripiprazole.REF.16">D'Urso, G., A.
|
|
Anastasia, E.
|
|
Toscano, S.
|
|
Patti, and A.
|
|
de Bartolomeis, Aripiprazole-induced atrial fibrillation in a patient with concomitant risk factors.
|
|
Exp Clin Psychopharmacol, 2018. 26(5): p. 509-513.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/30035575" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30035575</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>17.</dt><dd><div class="bk_ref" id="aripiprazole.REF.17">Mazer-Amirshahi, M., R.
|
|
Porter, and K.
|
|
Dewey, Prolonged QRS Widening After Aripiprazole Overdose.
|
|
Pediatr Emerg Care, 2019. 35(11): p. e209-e212.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/29746361" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29746361</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>18.</dt><dd><div class="bk_ref" id="aripiprazole.REF.18">Koller, D., S.
|
|
Almenara, G.
|
|
Mejia, M.
|
|
Saiz-Rodriguez, et al., Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial.
|
|
Hum Psychopharmacol, 2020.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/32991788" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32991788</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>19.</dt><dd><div class="bk_ref" id="aripiprazole.REF.19"><em>Aripiprazole</em>. 2019 20 July 2019 [cited 2020 17 July 2020]; Available from: <a href="https://www.ncbi.nlm.nih.gov/books/NBK501016/" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https://www<wbr style="display:inline-block"></wbr>​.ncbi.nlm<wbr style="display:inline-block"></wbr>​.nih.gov/books/NBK501016/</a>.</div></dd></dl><dl class="bkr_refwrap"><dt>20.</dt><dd><div class="bk_ref" id="aripiprazole.REF.20">Reny, J.L. and P.
|
|
Fontana, Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies?
|
|
Expert Opin Pharmacother, 2015. 16(4): p. 449-52.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/25495963" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25495963</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>21.</dt><dd><div class="bk_ref" id="aripiprazole.REF.21">Caudle, K.E., K.
|
|
Sangkuhl, M.
|
|
Whirl-Carrillo, J.J.
|
|
Swen, et al., Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.
|
|
Clin Transl Sci, 2020. 13(1): p. 116-124.
|
|
[<a href="/pmc/articles/PMC6951851/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6951851</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31647186" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31647186</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>22.</dt><dd><div class="bk_ref" id="aripiprazole.REF.22">CPIC. <em>CPIC® Guideline for Codeine and CYP2D6</em>. 2019 October 2019 [cited 2020 2020 June ]; Available from: <a href="https://cpicpgx.org/guidelines/guideline-for-codeine-and-cyp2d6/" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https://cpicpgx<wbr style="display:inline-block"></wbr>​.org/guidelines<wbr style="display:inline-block"></wbr>​/guideline-for-codeine-and-cyp2d6/</a>.</div></dd></dl><dl class="bkr_refwrap"><dt>23.</dt><dd><div class="bk_ref" id="aripiprazole.REF.23">Yokota, H., S.
|
|
Tamura, H.
|
|
Furuya, S.
|
|
Kimura, et al., Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism.
|
|
Pharmacogenetics, 1993. 3(5): p. 256-63.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/8287064" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8287064</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>24.</dt><dd><div class="bk_ref" id="aripiprazole.REF.24">PharmGKB [Internet]. Palo Alto (CA): Stanford University. Aripiprazole Variant Annotations [Cited 2020 July 30]. Available from <a href="https://www.pharmgkb.org/chemical/PA10026/variantAnnotation" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https://www<wbr style="display:inline-block"></wbr>​.pharmgkb<wbr style="display:inline-block"></wbr>​.org/chemical/PA10026/variantAnnotation</a>.</div></dd></dl><dl class="bkr_refwrap"><dt>25.</dt><dd><div class="bk_ref" id="aripiprazole.REF.25">Ingelman-Sundberg, M., Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.
|
|
Pharmacogenomics J, 2005. 5(1): p. 6-13.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/15492763" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15492763</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>26.</dt><dd><div class="bk_ref" id="aripiprazole.REF.26">PharmGKB [Internet]. Palo Alto (CA): Stanford University. Haplotype CYP2D6*4 [Cited 2012 July 24]. Available from <a href="http://www.pharmgkb.org/haplotype/PA165816579" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">http://www<wbr style="display:inline-block"></wbr>​.pharmgkb.org<wbr style="display:inline-block"></wbr>​/haplotype/PA165816579</a>.</div></dd></dl><dl class="bkr_refwrap"><dt>27.</dt><dd><div class="bk_ref" id="aripiprazole.REF.27">PharmGKB [Internet]. Palo Alto (CA): Stanford University. Haplotype CYP2D6*6 [Cited 2012 July 24]. Available from <a href="http://www.pharmgkb.org/haplotype/PA165816581" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">http://www<wbr style="display:inline-block"></wbr>​.pharmgkb.org<wbr style="display:inline-block"></wbr>​/haplotype/PA165816581</a>.</div></dd></dl><dl class="bkr_refwrap"><dt>28.</dt><dd><div class="bk_ref" id="aripiprazole.REF.28">PharmGKB [Internet]. Palo Alto (CA): Stanford University. Haplotype CYP2D6*10 [Cited 2012 July 24]. Available from <a href="http://www.pharmgkb.org/haplotype/PA165816582" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">http://www<wbr style="display:inline-block"></wbr>​.pharmgkb.org<wbr style="display:inline-block"></wbr>​/haplotype/PA165816582</a>.</div></dd></dl><dl class="bkr_refwrap"><dt>29.</dt><dd><div class="bk_ref" id="aripiprazole.REF.29">Bradford, L.D., CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.
|
|
Pharmacogenomics, 2002. 3(2): p. 229-43.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/11972444" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11972444</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>30.</dt><dd><div class="bk_ref" id="aripiprazole.REF.30">Zhou, Y., M.
|
|
Ingelman-Sundberg, and V.M.
|
|
Lauschke, Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects.
|
|
Clin Pharmacol Ther, 2017. 102(4): p. 688-700.
|
|
[<a href="/pmc/articles/PMC5600063/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5600063</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28378927" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28378927</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>31.</dt><dd><div class="bk_ref" id="aripiprazole.REF.31">Ramamoorthy, A., D.A.
|
|
Flockhart, N.
|
|
Hosono, M.
|
|
Kubo, et al., Differential quantification of CYP2D6 gene copy number by four different quantitative real-time PCR assays.
|
|
Pharmacogenet Genomics, 2010. 20(7): p. 451-4.
|
|
[<a href="/pmc/articles/PMC4411953/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4411953</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20421845" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 20421845</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>32.</dt><dd><div class="bk_ref" id="aripiprazole.REF.32">Del Tredici, A.L., A.
|
|
Malhotra, M.
|
|
Dedek, F.
|
|
Espin, et al., Frequency of CYP2D6 Alleles Including Structural Variants in the United States.
|
|
Front Pharmacol, 2018. 9: p. 305.
|
|
[<a href="/pmc/articles/PMC5895772/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5895772</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29674966" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29674966</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>33.</dt><dd><div class="bk_ref" id="aripiprazole.REF.33">Wu, X., L.
|
|
Yuan, J.
|
|
Zuo, J.
|
|
Lv, and T.
|
|
Guo, The impact of CYP2D6 polymorphisms on the pharmacokinetics of codeine and its metabolites in Mongolian Chinese subjects.
|
|
Eur J Clin Pharmacol, 2014. 70(1): p. 57-63.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/24077935" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24077935</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>34.</dt><dd><div class="bk_ref" id="aripiprazole.REF.34">Hosono, N., M.
|
|
Kato, K.
|
|
Kiyotani, T.
|
|
Mushiroda, et al., CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detection.
|
|
Clin Chem, 2009. 55(8): p. 1546-54.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/19541866" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 19541866</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>35.</dt><dd><div class="bk_ref" id="aripiprazole.REF.35">Gaedigk, A., L.D.
|
|
Bradford, S.W.
|
|
Alander, and J.S.
|
|
Leeder, CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.
|
|
Drug Metab Dispos, 2006. 34(4): p. 563-9.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/16415111" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 16415111</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>36.</dt><dd><div class="bk_ref" id="aripiprazole.REF.36">Sistonen, J., A.
|
|
Sajantila, O.
|
|
Lao, J.
|
|
Corander, et al., CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure.
|
|
Pharmacogenet Genomics, 2007. 17(2): p. 93-101.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/17301689" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 17301689</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>37.</dt><dd><div class="bk_ref" id="aripiprazole.REF.37">Khalaj, Z., Z.
|
|
Baratieh, P.
|
|
Nikpour, H.
|
|
Khanahmad, et al., Distribution of CYP2D6 polymorphism in the Middle Eastern region.
|
|
J Res Med Sci, 2019. 24: p. 61.
|
|
[<a href="/pmc/articles/PMC6670283/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6670283</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31523247" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31523247</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>38.</dt><dd><div class="bk_ref" id="aripiprazole.REF.38">Petrovic, J., V.
|
|
Pesic, and V.M.
|
|
Lauschke, Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe.
|
|
Eur J Hum Genet, 2020. 28(1): p. 88-94.
|
|
[<a href="/pmc/articles/PMC6906321/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6906321</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31358955" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31358955</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>39.</dt><dd><div class="bk_ref" id="aripiprazole.REF.39">Virbalas, J., B.E.
|
|
Morrow, D.
|
|
Reynolds, J.P.
|
|
Bent, and T.J.
|
|
Ow, The Prevalence of Ultrarapid Metabolizers of Codeine in a Diverse Urban Population.
|
|
Otolaryngol Head Neck Surg, 2019. 160(3): p. 420-425.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/30322340" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30322340</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>40.</dt><dd><div class="bk_ref" id="aripiprazole.REF.40">PharmGKB [Internet]. Palo Alto (CA): Stanford University. Drug/Small Molecule: Codeine [Cited 2020 June 24]. Available from <a href="http://www.pharmgkb.org/drug/PA449088" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">http://www<wbr style="display:inline-block"></wbr>​.pharmgkb.org/drug/PA449088</a>.</div></dd></dl><dl class="bkr_refwrap"><dt>41.</dt><dd><div class="bk_ref" id="aripiprazole.REF.41">Ingelman-Sundberg, M., S.C.
|
|
Sim, A.
|
|
Gomez, and C.
|
|
Rodriguez-Antona, Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
|
|
Pharmacology & therapeutics, 2007. 116(3): p. 496-526.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/18001838" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18001838</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>42.</dt><dd><div class="bk_ref" id="aripiprazole.REF.42">Ingelman-Sundberg, M., Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.
|
|
The pharmacogenomics journal, 2005. 5(1): p. 6-13.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/15492763" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15492763</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>43.</dt><dd><div class="bk_ref" id="aripiprazole.REF.43">Codeine sulfate tablets for oral use [package insert]. Philadelphia, PA: Lannett Company, I.; 2019. Available from: <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5819bdf7-300e-45b8-8f3a-447b53656293" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">https://dailymed<wbr style="display:inline-block"></wbr>​.nlm<wbr style="display:inline-block"></wbr>​.nih.gov/dailymed/drugInfo<wbr style="display:inline-block"></wbr>​.cfm?setid=5819bdf7-300e-45b8-8f3a-447b53656293</a></div></dd></dl><dl class="bkr_refwrap"><dt>44.</dt><dd><div class="bk_ref" id="aripiprazole.REF.44">van der Weide, K. and J.
|
|
van der Weide, The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients.
|
|
J Clin Psychopharmacol, 2015. 35(3): p. 228-36.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/25868121" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25868121</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>45.</dt><dd><div class="bk_ref" id="aripiprazole.REF.45">Hendset, M., E.
|
|
Molden, M.
|
|
Knape, and M.
|
|
Hermann, Serum concentrations of risperidone and aripiprazole in subgroups encoding CYP2D6 intermediate metabolizer phenotype.
|
|
Ther Drug Monit, 2014. 36(1): p. 80-5.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/24232129" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24232129</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>46.</dt><dd><div class="bk_ref" id="aripiprazole.REF.46">Lisbeth, P., H.
|
|
Vincent, M.
|
|
Kristof, S.
|
|
Bernard, et al., Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol.
|
|
Eur J Clin Pharmacol, 2016. 72(2): p. 175-84.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/26514968" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26514968</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>47.</dt><dd><div class="bk_ref" id="aripiprazole.REF.47">Kiss, A., A.
|
|
Menus, K.
|
|
Toth, M.
|
|
Deri, et al., Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure.
|
|
Eur Arch Psychiatry Clin Neurosci, 2020. 270(1): p. 71-82.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/30604050" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30604050</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>48.</dt><dd><div class="bk_ref" id="aripiprazole.REF.48">Jallaq, S.A., M.
|
|
Verba, J.R.
|
|
Strawn, L.J.
|
|
Martin, et al., CYP2D6 Phenotype Influences Aripiprazole Tolerability in Pediatric Patients with Mood Disorders.
|
|
J Child Adolesc Psychopharmacol, 2020.
|
|
[<a href="/pmc/articles/PMC8255312/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8255312</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32845723" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32845723</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>49.</dt><dd><div class="bk_ref" id="aripiprazole.REF.49">Matos, A., K.T.
|
|
Bain, D.L.
|
|
Bankes, A.
|
|
Furman, et al., Cytochrome P450 (CYP450) Interactions Involving Atypical Antipsychotics are Common in Community-Dwelling Older Adults Treated for Behavioral and Psychological Symptoms of Dementia.
|
|
Pharmacy (Basel), 2020. 8(2).
|
|
[<a href="/pmc/articles/PMC7355621/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC7355621</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32276526" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32276526</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>50.</dt><dd><div class="bk_ref" id="aripiprazole.REF.50">Hicks, J.K., J.J.
|
|
Swen, and A.
|
|
Gaedigk, Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization.
|
|
Curr Drug Metab, 2014. 15(2): p. 218-32.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/24524666" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24524666</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>51.</dt><dd><div class="bk_ref" id="aripiprazole.REF.51">Pratt, V.M., L.H.
|
|
Cavallari, A.L.
|
|
Del Tredici, A.
|
|
Gaedigk, et al., Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and European Society for Pharmacogenomics and Personalized Therapy.
|
|
J Mol Diagn, 2021.
|
|
[<a href="/pmc/articles/PMC8579245/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8579245</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34118403" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34118403</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>52.</dt><dd><div class="bk_ref" id="aripiprazole.REF.52">den Dunnen, J.T., R.
|
|
Dalgleish, D.R.
|
|
Maglott, R.K.
|
|
Hart, et al., HGVS Recommendations for the Description of Sequence Variants: 2016 Update.
|
|
Hum Mutat, 2016. 37(6): p. 564-9.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/26931183" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26931183</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>53.</dt><dd><div class="bk_ref" id="aripiprazole.REF.53">Gaedigk, A., S.T.
|
|
Casey, M.
|
|
Whirl-Carrillo, N.A.
|
|
Miller, and T.E.
|
|
Klein, Pharmacogene Variation Consortium<em>:</em>
|
|
A Global Resource and Repository for Pharmacogene Variation.
|
|
Clin Pharmacol Ther, 2021. 110(3): p. 542-545.
|
|
[<a href="/pmc/articles/PMC8725060/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC8725060</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34091888" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 34091888</span></a>]</div></dd></dl></dl></div><h2 id="NBK385288_footnotes">Footnotes</h2><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt>
|
|
<sup>1</sup>
|
|
</dt><dd><div id="aripiprazole.FN1"><p class="no_top_margin"> The FDA labels specific drug formulations. We have substituted the generic names for any drug labels in this excerpt. The FDA may not have labeled all formulations containing the generic drug. Certain terms, genes and genetic variants may be corrected in accordance with nomenclature standards, where necessary. We have given the full name of abbreviations, shown in square brackets, where necessary.</p></div></dd></dl></dl><div id="bk_toc_contnr"></div></div></div><div class="fm-sec"><h2 id="_NBK385288_pubdet_">Publication Details</h2><h3>Author Information and Affiliations</h3><p class="contrib-group"><h4>Authors</h4><span itemprop="author">Laura Dean</span>, MD<sup>1</sup> and <span itemprop="author">Megan Kane</span>, PhD<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>2</sup>.</p><h4>Affiliations</h4><div class="affiliation"><sup>1</sup> NCBI<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.mln.ibcn@sgm" class="oemail">vog.hin.mln.ibcn@sgm</a></div></div><div class="affiliation"><sup>2</sup> NCBI<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.mln.ibcn@sgm" class="oemail">vog.hin.mln.ibcn@sgm</a></div></div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><h3>Publication History</h3><p class="small">Created: <span itemprop="datePublished">September 22, 2016</span>; Last Revision: <span itemprop="dateModified">January 17, 2025</span>.</p><h3>Copyright</h3><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a><p class="small">All Medical Genetics Summaries content, except where otherwise noted, is licensed under a Creative Commons <a href="https://creativecommons.org/licenses/by/4.0/" ref="pagearea=meta&targetsite=external&targetcat=link&targettype=uri">Attribution 4.0 International (CC BY 4.0)</a> license which permits copying, distribution, and adaptation of the work, provided the original work is properly cited and any changes from the original work are properly indicated. Any altered, transformed, or adapted form of the work may only be distributed under the same or similar license to this one.</p></div></div><h3>Publisher</h3><p><a href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=books" ref="pagearea=page-banner&targetsite=external&targetcat=link&targettype=publisher">National Center for Biotechnology Information (US)</a>, Bethesda (MD)</p><h3>NLM Citation</h3><p>Dean L, Kane M. Aripiprazole Therapy and CYP2D6 Genotype. 2016 Sep 22 [Updated 2025 Jan 17]. In: Pratt VM, Scott SA, Pirmohamed M, et al., editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-. <span class="bk_cite_avail"></span></p></div><div class="small-screen-prev"><a href="/books/n/gtrbook/amitriptyline/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="small-screen-next"><a href="/books/n/gtrbook/atazanavir/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></article><article data-type="table-wrap" id="figobaripiprazoleTthefdadosingrecommenda"><div id="aripiprazole.T.the_fda_dosing_recommenda" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>The FDA Dosing Recommendations for Aripiprazole and CYP2D6 Metabolizer Status and Comedications (2020)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK385288/table/aripiprazole.T.the_fda_dosing_recommenda/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aripiprazole.T.the_fda_dosing_recommenda_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_aripiprazole.T.the_fda_dosing_recommenda_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Factors</th><th id="hd_h_aripiprazole.T.the_fda_dosing_recommenda_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Dosage adjustments for aripiprazole tablets</th></tr></thead><tbody><tr><td headers="hd_h_aripiprazole.T.the_fda_dosing_recommenda_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Known CYP2D6 poor metabolizers</td><td headers="hd_h_aripiprazole.T.the_fda_dosing_recommenda_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Administer half of usual dose</td></tr><tr><td headers="hd_h_aripiprazole.T.the_fda_dosing_recommenda_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Known CYP2D6 poor metabolizers taking concomitant strong CYP3A4 inhibitors (for example, itraconazole, clarithromycin)</td><td headers="hd_h_aripiprazole.T.the_fda_dosing_recommenda_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Administer a quarter of usual dose</td></tr><tr><td headers="hd_h_aripiprazole.T.the_fda_dosing_recommenda_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Strong CYP2D6 (for example, quinidine, fluoxetine, paroxetine) or CYP3A4 inhibitors (for example, itraconazole, clarithromycin)</td><td headers="hd_h_aripiprazole.T.the_fda_dosing_recommenda_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Administer half of usual dose</td></tr><tr><td headers="hd_h_aripiprazole.T.the_fda_dosing_recommenda_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Strong CYP2D6 and CYP3A4 inhibitors</td><td headers="hd_h_aripiprazole.T.the_fda_dosing_recommenda_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Administer a quarter of usual dose</td></tr><tr><td headers="hd_h_aripiprazole.T.the_fda_dosing_recommenda_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Strong CYP3A4 inducers (for example, carbamazepine, rifampin)</td><td headers="hd_h_aripiprazole.T.the_fda_dosing_recommenda_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Double usual dose over 1–2 weeks</td></tr></tbody></table></div><div class="tblwrap-foot"><div><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_margin">This FDA table is adapted from (<a class="bibr" href="#aripiprazole.REF.1" rid="aripiprazole.REF.1">1</a>).</p></div></dd></dl></dl></div></div></div></article><article data-type="table-wrap" id="figobaripiprazoleTthedpwgdosingrecommend"><div id="aripiprazole.T.the_dpwg_dosing_recommend" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>The DPWG Dosing Recommendations for Aripiprazole and CYP2D6 Metabolizer Status (2018)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK385288/table/aripiprazole.T.the_dpwg_dosing_recommend/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aripiprazole.T.the_dpwg_dosing_recommend_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_aripiprazole.T.the_dpwg_dosing_recommend_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CYP2D6 metabolizer type</th><th id="hd_h_aripiprazole.T.the_dpwg_dosing_recommend_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Action needed</th><th id="hd_h_aripiprazole.T.the_dpwg_dosing_recommend_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Background</th></tr></thead><tbody><tr><td headers="hd_h_aripiprazole.T.the_dpwg_dosing_recommend_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Poor metabolizer</td><td headers="hd_h_aripiprazole.T.the_dpwg_dosing_recommend_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Administer no more than 10 mg/day or 300 mg/month (67–75% of the standard maximum dose of aripiprazole)<sup>1</sup></td><td headers="hd_h_aripiprazole.T.the_dpwg_dosing_recommend_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">The risk of side effects is increased. The genetic variation leads to an increase in the sum of the plasma concentrations of aripiprazole and the active metabolite.</td></tr><tr><td headers="hd_h_aripiprazole.T.the_dpwg_dosing_recommend_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Intermediate metabolizer (IM)</td><td headers="hd_h_aripiprazole.T.the_dpwg_dosing_recommend_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:top;">NO action is needed for this gene-drug interaction</td><td headers="hd_h_aripiprazole.T.the_dpwg_dosing_recommend_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:top;">The genetic variation alters the plasma concentration of the sum of aripiprazole and the active metabolite dehydroaripiprazole to a limited degree. There is no evidence that this increases the risk of reduced effectiveness for UM or risk of side effects for IM.</td></tr><tr><td headers="hd_h_aripiprazole.T.the_dpwg_dosing_recommend_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Ultrarapid metabolizer (UM)</td></tr></tbody></table></div><div class="tblwrap-foot"><div><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_margin">DPWG: Dutch Pharmacogenetics Working Group</p></div></dd></dl><dl class="bkr_refwrap"><dt><sup>1</sup>
|
|
</dt><dd><div id="aripiprazole.TF.2.1"><p class="no_margin">Drug labeling within the European Union states that 15 mg/day is the starting maximum dose (<a class="bibr" href="#aripiprazole.REF.9" rid="aripiprazole.REF.9">9</a>).</p></div></dd></dl><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_margin">This DPWG table is adapted from (<a class="bibr" href="#aripiprazole.REF.4" rid="aripiprazole.REF.4">4</a>) .</p></div></dd></dl></dl></div></div></div></article><article data-type="table-wrap" id="figobaripiprazoleTactivitystatusofselect"><div id="aripiprazole.T.activity_status_of_select" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Activity Status of Selected CYP2D6 Alleles</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK385288/table/aripiprazole.T.activity_status_of_select/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aripiprazole.T.activity_status_of_select_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_aripiprazole.T.activity_status_of_select_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Allele type</th><th id="hd_h_aripiprazole.T.activity_status_of_select_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Activity score</th><th id="hd_h_aripiprazole.T.activity_status_of_select_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>CYP2D6</i> alleles</th></tr></thead><tbody><tr><td headers="hd_h_aripiprazole.T.activity_status_of_select_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Normal function</td><td headers="hd_h_aripiprazole.T.activity_status_of_select_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">1.0</td><td headers="hd_h_aripiprazole.T.activity_status_of_select_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
|
<i>*1, *2, *27, *33</i>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.T.activity_status_of_select_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Decreased function</td><td headers="hd_h_aripiprazole.T.activity_status_of_select_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">0.25-0.5</td><td headers="hd_h_aripiprazole.T.activity_status_of_select_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
|
<i>*10, *17, *41, *49</i>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.T.activity_status_of_select_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">No function</td><td headers="hd_h_aripiprazole.T.activity_status_of_select_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">0</td><td headers="hd_h_aripiprazole.T.activity_status_of_select_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
|
<i>*3, *4, *5, *6, *36</i>
|
|
</td></tr></tbody></table></div><div class="tblwrap-foot"><div><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_margin">For a comprehensive list of <i>CYP2D6</i> alleles, please See <a href="https://www.pharmvar.org/gene/CYP2D6" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">PharmVar</a>. Activity scores from (<a class="bibr" href="#aripiprazole.REF.22" rid="aripiprazole.REF.22">22</a>).</p></div></dd></dl></dl></div></div></div></article><article data-type="table-wrap" id="figobaripiprazoleTe"><div id="aripiprazole.Te" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK385288/table/aripiprazole.Te/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__aripiprazole.Te_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_aripiprazole.Te_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_aripiprazole.Te_1_1_1_1" style="text-align:left;vertical-align:middle;">Common allele name</th><th id="hd_h_aripiprazole.Te_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_aripiprazole.Te_1_1_1_2" style="text-align:left;vertical-align:middle;">Alternative names</th><th id="hd_h_aripiprazole.Te_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">HGVS reference sequence</th><th id="hd_h_aripiprazole.Te_1_1_1_4" rowspan="2" scope="col" colspan="1" headers="hd_h_aripiprazole.Te_1_1_1_4" style="text-align:left;vertical-align:middle;">dbSNP reference identifier for allele location</th></tr><tr><th headers="hd_h_aripiprazole.Te_1_1_1_3" id="hd_h_aripiprazole.Te_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Coding</th><th headers="hd_h_aripiprazole.Te_1_1_1_3" id="hd_h_aripiprazole.Te_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Protein</th></tr></thead><tbody><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*2<sup>[1]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2851C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242771/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.886C>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Arg296Cys</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs16947" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs16947</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Ser486Thr</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*3<sup>[1]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2550delA</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16894" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.775del</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Arg259fs</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs35742686" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs35742686</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*4<sup>[1]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1846G>A</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16889/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.506-1G>A</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant occurs in a non-coding region (splice variant causes a frameshift)</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs3892097" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs3892097</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*5<sup>[1]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2 hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1 hd_h_aripiprazole.Te_1_1_2_2 hd_h_aripiprazole.Te_1_1_1_4" colspan="4" rowspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16890/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Gene deletion</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*6<sup>[1]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1707 del T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16891/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.454delT</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Trp152Glyfs</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs5030655" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs5030655</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*7<sup>[2]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2936A>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/39385" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.971A>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.His324Pro</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs5030867" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs5030867</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*8<sup>[2]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1759G>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/39385/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.505G>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.His324Pro</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs5030865" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs5030865</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">2851C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16895/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.886C>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Cys296Arg</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs16947" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs16947</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Ser486Thr</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*9<sup>[1]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2616delAAG</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/617719" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.841_843del</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Lys281del</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs5030656" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs5030656</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*10<sup>[1]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16893/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.100C>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Pro34Ser</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1065852" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1065852</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:bottom;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/830235/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Ser486Thr</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*17<sup>[1]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1022C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/39379/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.320C>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Thr107Ile</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs28371706" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs28371706</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">2851C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16895/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.886C>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Cys296Arg</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs16947" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs16947</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:bottom;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/830235/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Ser486Thr</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*12<sup>[2]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">124G>A</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/39387/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.124G>A</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Gly42Arg</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs5030862" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs5030862</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">2851C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16895/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.886C>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Cys296Arg</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs16947" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs16947</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Ser486Thr</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*14<sup>[2]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1759G>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/39385/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.505G>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.His324Pro</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs5030865" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs5030865</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">2851C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16895/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.886C>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Cys296Arg</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs16947" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs16947</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Ser486Thr</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*15<sup>[2]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">137_138insT</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/678343" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.137dup</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Leu47fs</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs774671100" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs774671100</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*21<sup>[2]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2580_2581insC</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/392513720" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.5</a>:c.805dup</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Arg269fs</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs72549352" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs72549352</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">2851C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16895/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.886C>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Cys296Arg</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs16947" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs16947</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Ser486Thr</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*28</td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19G>A</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.19G>A</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Val7Met</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs72549358" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs72549358</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">1705C>G</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.451C>G</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Gln151Glu</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs78482768" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs78482768</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">2851C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="/clinvar/variation/16895/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.886T>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="/clinvar/variation/16895/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_000097.3:p.Cys296Arg</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs16947" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs16947</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Ser486Thr</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*29<sup>[1]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1660G>A+1662G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.406G>A + <a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.408G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Val136Met +<br /><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Val136=</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;"><a href="https://www.ncbi.nlm.nih.gov/snp/rs61736512" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs61736512</a> +<br /><a href="https://www.ncbi.nlm.nih.gov/snp/rs1058164" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1058164</a></td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">2851C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="/clinvar/variation/16895/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.886T>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="/clinvar/variation/16895/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_000097.3:p.Cys296Arg</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs16947" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs16947</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">3184G>A</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/598263/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1012G>A</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Val338Met</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs59421388" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs59421388</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Ser486Thr</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*31<sup>[2]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2851C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242771/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.886C>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Arg296Cys</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs16947/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs16947</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4043G>A</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/183247/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1319G>A</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Arg440His</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs267608319" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs267608319</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.1457G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_000097.3:p.Ser486Thr</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="8" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*36<sup>[3]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16893/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.100C>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16893/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_000097.3:p.Pro34Ser</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1065852" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1065852</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4129C>G</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.1405C>G</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Pro469Ala</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135833" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135833</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4132A>G</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.1408A>G</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Thr470Ala</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135835" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135835</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4156C>T+4157A>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.1432C>T+ <a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.1433A>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.His47Ser</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/snp/rs28371735" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs28371735</a>+ <a href="https://www.ncbi.nlm.nih.gov/snp/rs766507177" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs766507177</a></td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4159G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.1435G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NP_00097.3:p.Gly479Arg</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4165T>G</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.1441T>G</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NP_00097.3:p.Phe481Val</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4168G>A+4169C>G</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.1444G>A+ <a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.1445C>G</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Ala482Ser</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/snp/rs74478221" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs74478221</a>+ <a href="https://www.ncbi.nlm.nih.gov/snp/rs75467367" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs75467367</a></td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_000097.3:p.Ser486Thr</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D4*40<sup>[2]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1022C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.320C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Thr107Ile</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs28371706" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs28371706</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">1864_1865insTTTCGCCCC[2]</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.514TTTCGCCCC[3]</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.172FRP[3]</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs72549356" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs72549356</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">2851C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242771/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.886C>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Arg296Cys</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs16947/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs16947</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_000097.3:p.Ser486Thr</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*41<sup>[1]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2851C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="/clinvar/variation/16895/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.886T>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="/clinvar/variation/16895/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_000097.3:p.Cys296Arg</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs16947" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs16947</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">2989G>A</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/39381/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.985+39G>A</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant occurs in a non-coding region (impacts slicing).</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs28371725" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs28371725</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:bottom;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/830235/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/830235/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_000097.3:p.Ser486Thr</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*49<sup>[2]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">100C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16893/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.100C>T</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/16893/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_000097.3:p.Pro34Ser</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1065852" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1065852</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:bottom;">1612T>A</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">NM_00106.6:c.358T>A</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Phe120Ile</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135822" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135822</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_000097.3:p.Ser486Thr</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*56<sup>[2]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3202C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.1030C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Arg344Ter</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs72549347" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs72549347</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_000097.3:p.Ser486Thr</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">CYP2D6*59<sup>[2]</sup></td><td headers="hd_h_aripiprazole.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2851C>T</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="/clinvar/variation/16895/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.886T>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="/clinvar/variation/16895/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_000097.3:p.Cys296Arg</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs16947" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs16947</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">2940G>A</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/1435110251" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=nuccore">NM_000106.6</a>:c.975G>A</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/protein/392513721/?report=GenPept" class="bk_tag" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=genpept">NP_000097.3</a>:p.Pro325=</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs79292917" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs79292917</a>
|
|
</td></tr><tr><td headers="hd_h_aripiprazole.Te_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">4181G>C</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NM_000106.6:c.1457G>C</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_3 hd_h_aripiprazole.Te_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/clinvar/variation/242701/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NP_000097.3:p.Ser486Thr</a>
|
|
</td><td headers="hd_h_aripiprazole.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">
|
|
<a href="https://www.ncbi.nlm.nih.gov/snp/rs1135840" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">rs1135840</a>
|
|
</td></tr></tbody></table></div><div class="tblwrap-foot"><div><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt>
|
|
<sup>[1]</sup>
|
|
</dt><dd><div id="aripiprazole.TF.e.1"><p class="no_margin">AMP Tier 1 allele, (<a class="bibr" href="#aripiprazole.REF.51" rid="aripiprazole.REF.51">51</a>)</p></div></dd></dl><dl class="bkr_refwrap"><dt>
|
|
<sup>[2]</sup>
|
|
</dt><dd><div id="aripiprazole.TF.e.2"><p class="no_margin">AMP Tier 2 allele, (<a class="bibr" href="#aripiprazole.REF.51" rid="aripiprazole.REF.51">51</a>)</p></div></dd></dl><dl class="bkr_refwrap"><dt>
|
|
<sup>[3]</sup>
|
|
</dt><dd><div id="aripiprazole.TF.e.3"><p class="no_margin"><i>CYP2D6*36</i> is a gene conversion with CYP2D7; variants provided here are from the Pharmacogene Variation Consortium.</p></div></dd></dl><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_margin">Alleles described in this table are selected based on discussion in the text above. This is not intended to be an exhaustive description of known alleles.</p></div></dd></dl><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_margin">Guidelines for the description and nomenclature of gene variations are available from the Human Genome Variation Society (<a class="bibr" href="#aripiprazole.REF.52" rid="aripiprazole.REF.52">52</a>).</p></div></dd></dl><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_margin">Nomenclature for Cytochrome P450 enzymes is available from the Pharmacogene Variation (<a href="http://www.pharmvar.org/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">PharmVar</a>) Consortium (<a class="bibr" href="#aripiprazole.REF.53" rid="aripiprazole.REF.53">53</a>).</p></div></dd></dl></dl></div></div></div></article></div><div id="jr-scripts"><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/libs.min.js"> </script><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.min.js"> </script><script type="text/javascript">if (typeof (jQuery) != 'undefined') { (function ($) { $(function () { var min = Math.ceil(1); var max = Math.floor(100000); var randomNum = Math.floor(Math.random() * (max - min)) + min; var surveyUrl = "/projects/Gene/portal/surveys/seqdbui-survey.js?rando=" + randomNum.toString(); $.getScript(surveyUrl, function () { try { ncbi.seqDbUISurvey.init(); } catch (err) { console.info(err); } }).fail(function (jqxhr, settings, exception) { console.info('Cannot load survey script', jqxhr); });; }); })(jQuery); };</script></div></div>
|
|
|
|
|
|
|
|
|
|
<!-- Book content -->
|
|
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal107 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3968615.js" snapshot="books"></script></body>
|
|
</html>
|